These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 23573785
1. Proteomics and NF-κB: an update. Niederberger E, Geisslinger G. Expert Rev Proteomics; 2013 Apr; 10(2):189-204. PubMed ID: 23573785 [Abstract] [Full Text] [Related]
2. Analysis of NF-kappaB signaling pathways by proteomic approaches. Niederberger E, Geisslinger G. Expert Rev Proteomics; 2010 Apr; 7(2):189-203. PubMed ID: 20377387 [Abstract] [Full Text] [Related]
3. Regulation and function of IKK and IKK-related kinases. Häcker H, Karin M. Sci STKE; 2006 Oct 17; 2006(357):re13. PubMed ID: 17047224 [Abstract] [Full Text] [Related]
5. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach. Egan LJ, Toruner M. Ann N Y Acad Sci; 2006 Aug 17; 1072():114-22. PubMed ID: 17057194 [Abstract] [Full Text] [Related]
9. Relevance of new drug discovery to reduce NF-κB activation in cardiovascular disease. Madonna R, De Caterina R. Vascul Pharmacol; 2012 Aug 19; 57(1):41-7. PubMed ID: 22366375 [Abstract] [Full Text] [Related]
10. Beyond IkappaBs: alternative regulation of NF-kappaB activity. Neumann M, Naumann M. FASEB J; 2007 Sep 19; 21(11):2642-54. PubMed ID: 17431096 [Abstract] [Full Text] [Related]
11. Control of NF-kappaB activation by the COP9 signalosome. Schweitzer K, Naumann M. Biochem Soc Trans; 2010 Feb 19; 38(Pt 1):156-61. PubMed ID: 20074051 [Abstract] [Full Text] [Related]
12. NF-kappaB-related genetic diseases. Courtois G, Smahi A. Cell Death Differ; 2006 May 19; 13(5):843-51. PubMed ID: 16397577 [Abstract] [Full Text] [Related]
13. Diverse ubiquitin signaling in NF-κB activation. Iwai K. Trends Cell Biol; 2012 Jul 19; 22(7):355-64. PubMed ID: 22543051 [Abstract] [Full Text] [Related]
14. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Viatour P, Merville MP, Bours V, Chariot A. Trends Biochem Sci; 2005 Jan 19; 30(1):43-52. PubMed ID: 15653325 [Abstract] [Full Text] [Related]
15. Deciphering the pathway from the TCR to NF-kappaB. Weil R, Israël A. Cell Death Differ; 2006 May 19; 13(5):826-33. PubMed ID: 16439988 [Abstract] [Full Text] [Related]
16. Regulation of NF-kappaB transcriptional activity. Vermeulen L, Vanden Berghe W, Haegeman G. Cancer Treat Res; 2006 May 19; 130():89-102. PubMed ID: 16610704 [Abstract] [Full Text] [Related]
17. A beginner's guide to NF-kappaB signaling pathways. Delhalle S, Blasius R, Dicato M, Diederich M. Ann N Y Acad Sci; 2004 Dec 19; 1030():1-13. PubMed ID: 15659775 [Abstract] [Full Text] [Related]
18. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma. Hosokawa Y. Apoptosis; 2005 Jan 19; 10(1):25-34. PubMed ID: 15711920 [Abstract] [Full Text] [Related]
19. NF-kappaB in liver diseases: a target for drug therapy. Muriel P. J Appl Toxicol; 2009 Mar 19; 29(2):91-100. PubMed ID: 18937212 [Abstract] [Full Text] [Related]
20. The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target. Yates LL, Górecki DC. Acta Biochim Pol; 2006 Mar 19; 53(4):651-62. PubMed ID: 17068636 [Abstract] [Full Text] [Related] Page: [Next] [New Search]